Abbott Laboratories (ABT) Change in Receivables (2009 - 2026)
Abbott Laboratories (ABT) posted Change in Receivables of $386.0 million for Q2 2026, up 819.05% sequentially from $42.0 million in Q1 2026, and down 5.85% YoY from $410.0 million in Q2 2025.
Abbott Laboratories (ABT) Change in Receivables (2009 - 2026) Analysis & Trends
Abbott Laboratories has reported Change in Receivables for 18 years, with the latest figure at $386.0 million in Q2 2026.
- Quarterly Change in Receivables fell 5.85% year-over-year to $386.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $408.0 million (down 54.0% YoY) and the FY2025 annual result came in at $652.0 million, down 5.64% from the prior year.
- Change in Receivables advanced to $386.0 million in Q2 2026 per ABT's latest filing, from $42.0 million in the prior quarter.
- Over five years, Change in Receivables peaked at $751.0 million in Q1 2022 and troughed at -$530.0 million in Q3 2022.
- A 5-year average of $121.9 million and a median of $173.0 million in 2022 frame the typical range for Change in Receivables.
- The widest YoY moves for Change in Receivables: up 637.14% in 2022, down 280.42% in 2022.
- Over 5 years, Change in Receivables stood at -$341.0 million in 2022, then surged by 80.06% to -$68.0 million in 2023, then jumped by 332.35% to $158.0 million in 2024, then sank by 240.51% to -$222.0 million in 2025, then surged by 273.87% to $386.0 million in 2026.
- According to Business Quant data, Change in Receivables over the past three periods registered $386.0 million, $42.0 million, and -$222.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 177.00 Mn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 46.00 Mn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 10.20 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 172.10 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 79.00 Mn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | - |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | -90.00 Mn |
| 10 | Zimmer Biomet Holdings | 19.32 Bn | 18.91 Bn | 1.54 Bn | 38.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 386.00 Mn |
| Jun 30, 2026 | 386.00 Mn |
| Mar 31, 2026 | 42.00 Mn |
| Mar 31, 2026 | 42.00 Mn |
| Dec 31, 2025 | -222.00 Mn |
| Dec 31, 2025 | -222.00 Mn |
| Sep 30, 2025 | 202.00 Mn |
| Sep 30, 2025 | 202.00 Mn |
| Jun 30, 2025 | 410.00 Mn |
| Jun 30, 2025 | 410.00 Mn |
| Mar 31, 2025 | 262.00 Mn |
| Mar 31, 2025 | 262.00 Mn |
| Dec 31, 2024 | 158.00 Mn |
| Dec 31, 2024 | 158.00 Mn |
| Sep 30, 2024 | 57.00 Mn |
| Sep 30, 2024 | 57.00 Mn |
| Jun 30, 2024 | 325.00 Mn |
| Jun 30, 2024 | 325.00 Mn |
| Mar 31, 2024 | 151.00 Mn |
| Mar 31, 2024 | 151.00 Mn |